XML 15 R4.htm IDEA: XBRL DOCUMENT v3.4.0.3
Condensed Consolidated Statements of Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Net sales $ 471,197 $ 472,821
Cost of goods sold 207,168 202,715
Gross profit 264,029 270,106
Selling, general and administrative expense 189,716 188,555
Research and Development Expense 48,586 47,202
Segment profit (loss) 25,727 34,349
Interest expense 5,580 5,002
Foreign exchange losses, net 1,129 3,806
Other (income) expense, net (1,177) (1,153)
Income before income taxes 20,195 26,694
Provision for income taxes (7,919) (8,876)
Net income including noncontrolling interests 12,276 17,818
Net income attributable to Bio-Rad $ 12,276 $ 17,818
Basic earnings per share:    
Net income per share basic attributable to Bio-Rad $ 0.42 $ 0.61
Weighted average common shares - basic 29,364 29,092
Diluted earnings per share:    
Net income per share diluted attributable to Bio-Rad $ 0.42 $ 0.61
Weighted average common shares - diluted 29,506 29,289